TITLE

Atypical Fractures and Bisphcsphcnate Therapy

AUTHOR(S)
Elliott, William T.
PUB. DATE
June 2010
SOURCE
Internal Medicine Alert;6/15/2010 Supplement, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on several topics related to pharmacology including the bisphosphonates therapy which is being associated for atypical fractures, warfarin anticoagulation, and the duration of clopidogrel dual antiplatlet therapy.
ACCESSION #
51707640

 

Related Articles

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;4/23/2011, Issue 1348/1349, p2 

    This section presents updates on pharmacology including the confirmation of the efficacy of bisphosphonates in preventing and treating bone disorders, a study on the link between narcolepsy and the use of the influenza A H1N1 vaccine, Pandemrix and the review being conducted by the U.S. Food and...

  • Zoledronic Acid: A Review of its Use in Patients with Advanced Cancer. Perry, Caroline M.; Figgitt, David P. // Drugs;2004, Vol. 64 Issue 11, p1197 

    Zoledronic acid (Zometa®), a parenteral bisphosphonate, is an inhibitor of osteoclast-mediated bone resorption and is used in the management of patients with cancer. Zoledronic acid 4mg is administered as an intravenous infusion over 15 minutes. In the treatment of bone metastases, zoledronic...

  • Bisphosphonates and their use. Mkele, Gail // South African Pharmaceutical Journal;2013, Vol. 80 Issue 8, p24 

    Bisphosphonates are a class of medicine used to treat bone disorders and malignancies associated with an increased risk of fractures. Their primary mechanism of action is inhibition of osteoclastic bone resorption. Over the past few years, a number of bisphosphonates and generics thereof have...

  • Cystic Bone Angiomatosis: A Case Report Treated with Aminobisphosphonates and Review of the Literature. Marcucci, Gemma; Masi, Laura; Carossino, Anna; Franchi, Alessandro; Capanna, Rodolfo; Sinigaglia, Luigi; Brandi, Maria // Calcified Tissue International;Nov2013, Vol. 93 Issue 5, p462 

    Cystic angiomatosis (CA) is a rare disease characterized by multifocal hemangiomatous and/or lymphangiomatous lesions of the skeleton with possible visceral organ involvement. The exact pathogenetic mechanism of the disease is still unknown. We describe a patient affected by CA of bone treated...

  • An alternative to bisphosphonates. McKernon, Sarah // Dental Nursing;Sep2015, Vol. 11 Issue 9, p544 

    The article discusses the impact on dental care of biphosphonates as alternative to denosumab for inhibiting osteoclastic bone resorption. Topics covered include risks for bisphosphonate-induced osteonecrosis of the jaw (BONJ), bone remodelling after an injury or tooth extraction and denosumab...

  • Alendronate given for 4 years continues to increase bone density.  // Geriatrics;Jan98, Vol. 53 Issue 1, p68 

    Focuses on the bisphosphonate alendronate sodium (Fosamax) and its ability to promote bone density in postmenopausal women with osteoporosis. Details on a two-year extension study conducted by Ronald Emkey, M.D., director of the Bone Research Center, Reading Hospital and Medical Center in West...

  • Alendronate prevents steroid-induced bone loss in men and women.  // Geriatrics;Jan98, Vol. 53 Issue 1, p69 

    Focuses on the use of the bisphosphonate alendronate sodium (Fosamax) as treatment for steriod-induced osteoporosis in both men and women. Details on a study conducted by Jacques P. Brown, M.D., a rheumatologist and principle investigator at the Clinical Research Unit of the Bone Disease...

  • Atypical Fractures and Bisphosphonate Therapy.  // Clinical Cardiology Alert;Jun2010 Pharmacology Watch, p1 

    The article presents a study which concluded that the occurrence of fracture of the diaphyseal femur was very rare among those who had been treated with bisphosphonate therapy for as long as 10 years.

  • Bisphosphonates.  // Reactions Weekly;6/5/2010, Issue 1304, p12 

    The article describes the case of 16 women patients who acquired femoral cortical stress lesions and fracture while undergoing treatment with biphosphonates.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics